According to our (Global Info Research) latest study, the global Vascular Closure Devices market size was valued at US$ 1225 million in 2024 and is forecast to a readjusted size of USD 1958 million by 2031 with a CAGR of 7.0% during review period.
Vascular closure devices are medical devices used to achieve hemostasis of the small hole in the artery after a cardiovascular procedure of endovascular surgery requiring a catheterization. The devices seal the puncture site in an artery (the arteriotomy) through mechanical means rather than relying on the body’s natural clotting response.
Vascular Closure Devices were introduced in the early 1990s in an effort to reduce the time to hemostasis, enable early ambulation and improve patient comfort. Initially, devices focused on technologies involving a suture or a collagen plug. These technologies are effective at closing the hole; however, they often leave an intravascular component in the artery, which can cause complications. In addition, these technologies failed to accurately address patient pain. More recent methods to close the hole involve the use of novel materials that dissolve over a short period of time, such as polyethylene glycol found in the Mynx vascular closure device. These technologies incorporate a more gentle deployment of the material to the outside of the artery and avoid the use of intravascular components, leaving nothing behind in the artery and consequently improving patient comfort.
Generally, there are two types of vascular closure devices: active and passive, in this report, vascular closure devices refer to active vascular closure devices.
Global core vascular closure devices manufacturers include Abbott Laboratories, Terumo Corporation, Cordis, Teleflex Incorporated and Morrris Innovative. The top 1 company hold a share over 50%. North America is the largest market, with a share about 45%, followed by Asia Pacific and Europe with the share about 30% and 25%. In terms of product type, 8F is the largest segment, with a share over 20%. And in terms of application, the largest application is interventional procedures, followed by angiography surgery.
This report is a detailed and comprehensive analysis for global Vascular Closure Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Vascular Closure Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Vascular Closure Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Vascular Closure Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Vascular Closure Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Vascular Closure Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Vascular Closure Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Terumo Corporation, Cordis, Teleflex Incorporated, Morrris Innovative, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Vascular Closure Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
5F
6F
7F
8F
Others
Market segment by Application
Angiography Surgery
Interventional Procedures
Major players covered
Abbott Laboratories
Terumo Corporation
Cordis
Teleflex Incorporated
Morrris Innovative
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vascular Closure Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vascular Closure Devices, with price, sales quantity, revenue, and global market share of Vascular Closure Devices from 2020 to 2025.
Chapter 3, the Vascular Closure Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vascular Closure Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Vascular Closure Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vascular Closure Devices.
Chapter 14 and 15, to describe Vascular Closure Devices sales channel, distributors, customers, research findings and conclusion.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook